Skip to main content
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.
Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma.
Role of radiotherapy in neuroblastoma.
Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy.